How do you make quality improvement a meaningful part of oncology fellowship training rather than a box fellows simply check?
Quality and Survivorship Training in Oncology Fellowship: Highlights
- There are multiple paths to oncology and fellowship, each have their own unique merits and benefits
- Surveys like Total Wellness are crucial to better understanding survivorship for patients with EGFR-mutated NSCLC
- The OncLive Fellows Forum is opportunity to network within oncology fields in a smaller, closer setting
We have a 3-part [quality improvement] series that we started, where we teach some of these [quality improvement] science techniques and also help our fellows do a project together. Going through all the different parts of [quality improvement] science, learning about [Plan-Do-Study-Act] cycles, and learning how to do a root cause analysis and understand the root of a problem are all important skills that you should have going into practice.
The most important skill that our fellows probably don’t think about is when you review morbidity and mortality cases. For us, morbidity, mortality, and improvement is the curriculum that we do: breaking down what went wrong and what errors were made, and then figuring out how all of us, whether at the individual level or the system level, can fix it and improve care for patients. That’s one skill that we spend time on and teach our fellows.
Is learning from medical errors the quality improvement skill that new fellows underestimate most?
I would say so. The world is a litigious environment. What fellows should take away from that part of our training is understanding that there are errors in the system. There are safety measures we put into place, but in any good Swiss cheese model, you can have one safety [measure], you miss something there, the holes line up, and then an error can happen. We need to talk about these things. We can’t improve unless we know exactly what we did wrong. That’s an important lesson: to be reflective, walk through a process, and learn what doesn’t work before you can try to fix it.
How can fellows be empowered to lead, not just contribute to, morbidity and mortality and patient safety discussions?
When I was a fellow, I led the morbidity and mortality conference in our fellowship program. It was something new that we had at UPMC, and thankfully my program director let me take the lead and run a case conference. For our fellows, it’s a great idea [for them to] lead the case conference themselves and walk the rest of the fellows through the cases. Internal medicine often does it, where the chief resident will run through the cases, too. That’s a good way to give them a leadership role within quality and patient safety.
What does survivorship care look like for patients with EGFR-mutated lung cancer who are living longer on targeted therapy?
This area I’m passionate about. Most patients with EGFR-mutated lung cancer are never smokers; often they’re younger [and] Asian [or] Pacific Islander. We have a survey for all our patients right now, and it’s available in [simplified] and traditional Chinese as well as Korean, based on our population of patients who have EGFR-mutated lung cancer. Many of our patients are parents; they have young children, and we don’t know enough about what their survivorship needs are, since much of lung cancer care has focused on heavier smokers and patients who don’t have targets.
Since we have such a large EGFR population, we’ve started this survey, and we call it Total Wellness. It’s about a 20- to 30-minute survey to get at what the survivorship needs are. Are patients having financial difficulty? What symptoms are they having? Who are they seeing? Where are they getting their information? Where do they prefer to get their information? It goes beyond that to nutrition, body image, and spiritual needs.
We’ll have a better sense of our population soon. We’re recruiting, and all our patients [are filling] it out if they’re interested. What survivorship looks like will be different. You’re thinking about people who may be the sandwich generation, taking care of older parents while also dealing with their lung cancer and taking care of their children. We’ll know a little bit more soon.
What we’re gathering is so rich, and it should inform what services we need to set up and what areas our physicians need to be equipped to discuss with their patients. In one of the surveys leading up to this, we asked all our primary care doctors, pulmonologists, and thoracic surgeons what people are asking them when it comes to their lung cancer, and whether they are referring them to pulmonary rehab, [dermatology], or functional medicine. We’ve gathered a lot of that data, too.
What can fellows gain from the OncLive National Fellows Forum: Lung Cancer that they can’t get at their home institution?
The [OncLive] Fellows Forum, I’m so excited about doing this again. I was part of the group 2 years ago, [and Kristen A. Marrone, MD,] and I were both in that group, and it was so much fun. The fellows who were there all got a chance to spend time one-on-one with faculty members or in small groups, [like] faculty members you might see on the podiums but were maybe too nervous to go up and talk to. It’s a small setting. It’s not just, [updates on] what’s happening in lung cancer. It’s mentorship. It’s relationships that you’re creating in this small forum that you’re going to carry forward.
It’s a great program, and I wish I had something like that when I was in training. It’s a way to not just get your foot in the door in lung cancer, or whatever topic the Fellows Forum is covering; it’s a way to get immersed in the community. You could go there and [say], “Lung cancer, that’s what I want to do. These are my people.” That’s what the [Fellows Forum] brings. Plus, this year, it’s me, [Narjust Florez, MD,] and [Ana Velazquez Mañana, MD, MSc, FASCO], and it’s going to be a blast.
References
- Goldberg SB. EGFR: how to make the best decision. Paper presented at: New York Lung Cancers Symposium; November 14, 2026; New York, NY
- OncLive. National Fellows Forum. Accessed November 10, 2026. https://www.onclive.com/national-fellows-forum